Cancer Management and Research: 2023, vol: 15, issue:
1)- . Isovitexin Suppresses Cancer Stemness Property and Induces Apoptosis of Osteosarcoma Cells by Disruption of the DNMT1/miR-34a/Bcl-2 Axis [Retraction].Cancer management and research. 2023, 15: 1003-1004
2)- . Downregulation of Circ_0071589 Suppresses Cisplatin Resistance in Colorectal Cancer by Regulating the MiR-526b-3p/KLF12 Axis [Retraction].Cancer management and research. 2023, 15: 1005-1006
3)- . Knockdown of CircCRIM1 Inhibits HDAC4 to Impede Osteosarcoma Proliferation, Migration, and Invasion and Facilitate Autophagy by Targeting miR-432-5p [Retraction].Cancer management and research. 2023, 15: 1007-1008
4)- . miR-4429 Regulates the Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Cervical Cancer by Targeting FOXM1 [Retraction].Cancer management and research. 2023, 15: 1009-1010
6)- . MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 [Retraction].Cancer management and research. 2023, 15: 1013-1014
7)- Mingshuang Wu, Chenxi Pan, Yi He, Bo Yang. A Novel Nomogram for Identifying the Patients at Risk for Rapid Progression of Advanced Hormone-Sensitive Prostate Cancer.Cancer management and research. 2023, 15: 1015-1024
8)- Pedro Luiz Serrano Uson Junior, Mitesh J Borad. Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date.Cancer management and research. 2023, 15: 1025-1031
10)- Yekosani Mitala, Brian Ssenkumba, Rita Nabulya, Francis Nsumba Kitenda, Habert Tumwesigye, Abraham Birungi, Richard Dratu Chau, Branchard Mushabe, Nichole Baker, Raymond Atwine. Primary Breast Burkitt Lymphoma. A Case Report of a 16-Year-Old Female with a Rapidly Growing Unilateral Breast Mass.Cancer management and research. 2023, 15: 1047-1052
11)- Jiahui Wu, Huidan Luo, Kun Wang, Bin Yi. Development and Validation of a Novel Diagnostic Nomogram Model Using Serum Oxidative Stress Markers and AURKA for Prediction of Nasopharyngeal Carcinoma.Cancer management and research. 2023, 15: 1053-1062
12)- Veronica Agostinelli, Lucia Musacchio, Floriana Camarda, Vanda Salutari, Maria Vittoria Carbone, Viola Ghizzoni, Camilla Nero, Caterina Ricci, Maria Teresa Perri, Elena Giudice, Sara Lardino, Rossana Berardi, Giovanni Scambia, Domenica Lorusso. Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data.Cancer management and research. 2023, 15: 1063-1072
13)- Haitao Li, Shengjin Fan, Dongxue Lu, Jin Zhou. A New Scoring System for Predicting Mortality in Hematological Malignancies with Sepsis: A Derivation and Validation Study.Cancer management and research. 2023, 15: 1073-1083
14)- Eda Caliskan Yildirim, Yusuf Acikgoz, Yakup Ergun, Efnan Algin, Oznur Bal. Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data.Cancer management and research. 2023, 15: 1085-1096
15)- ZhenDong Liu, YuYang Xu, Shan Jin, Xin Liu, BaoChun Wang. Construction of a Prognostic Model Based on Methylation-Related Genes in Patients with Colon Adenocarcinoma.Cancer management and research. 2023, 15: 1097-1110
16)- Yong Jung Song, Hwi Gon Kim, Hyung Joon Yoon, Kyung Un Choi, Dong Soo Suh, Ki Hyung Kim. Preoperative Haematologic Markers for the Differentiation of Endometrial Cancer from Benign Endometrial Lesions in Postmenopausal Patients with Endometrial Masses.Cancer management and research. 2023, 15: 1111-1121
19)- Hui Wu, Gui Zhen Weng, Li Na Sun, Zhang Chi Pan, Lu Zhang, Qiang Chen, Chun Mei Shi. T Cell Invigoration is Associated with the Clinical Response to Anti-PD-1-Based Immunotherapy in Non-Small Cell Lung Cancer.Cancer management and research. 2023, 15: 1141-1153
20)- Xia Li, Shuang Xu, Liu-Wei Hao, Xiao-Ning Zhou. Value of Molybdenum Target X-Ray and High-Frequency Color Doppler Flow Imaging in Early Diagnosis of Breast Carcinoma: A Comparative Analysis.Cancer management and research. 2023, 15: 1155-1163
23)- Andrea Ferrari, Pablo Berlanga, Susanne Andrea Gatz, Reineke A Schoot, Max M van Noesel, Shushan Hovsepyan, Stefano Chiaravalli, Luca Bergamaschi, Veronique Minard-Colin, Nadege Corradini, Rita Alaggio, Patrizia Gasparini, Bernadette Brennan, Michela Casanova, Sandro Pasquali, Daniel Orbach. Treatment at Relapse for Synovial Sarcoma of Children, Adolescents and Young Adults: From the State of Art to Future Clinical Perspectives.Cancer management and research. 2023, 15: 1183-1196
24)- Carielle Joy Rio, Taichi Goto, Chao-Pin Hsiao, Alexander L R Ross, Leorey N Saligan. Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer.Cancer management and research. 2023, 15: 1197-1206
25)- Yuling Cheng, Yu Zhu. Comparison of Perioperative Outcomes Between Laparoscopic and Robot-Assisted Adrenalectomy for Large Pheochromocytoma (≥ 5cm): A Retrospective Study.Cancer management and research. 2023, 15: 1207-1216
26)- Wubalech Temsegen, Kasahun Gorems, Mekidim Mekonnen, Diriba Fufa, Tesfaye Kassa. Fecal Carriage of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Enterobacteriaceae Among Oncology and Non-Oncology Patients at Jimma Medical Center in Ethiopia: A Comparative Cross-Sectional Study.Cancer management and research. 2023, 15: 1217-1231
27)- Madison Fraser, Nagashree Seetharamu, Matthew Diamond, Chung-Shien Lee. Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives.Cancer management and research. 2023, 15: 1233-1243
28)- Anna Clennon, Megan Hinkley, Kristen Nymberg, Lauren Ledbetter, Demond Handley, Eric McLaughlin, Amir Mortazavi, Katharine A Collier. Effect of Enfortumab Vedotin Dose Adjustment on Efficacy in Metastatic Urothelial Carcinoma: A Retrospective Single-Center Experience .Cancer management and research. 2023, 15: 1245-1250
32)- . LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p [Retraction].Cancer management and research. 2023, 15: 1267-1268
33)- . LINC00261 Inhibits Esophageal Cancer Radioresistance by Down-Regulating microRNA-552-3p and Promoting DIRAS1 [Retraction].Cancer management and research. 2023, 15: 1269-1270
34)- Pietro Quaglino, Paolo A Ascierto, Francesca Consoli, Paola Queirolo, Francesco Spagnolo, Maria Francesca Morelli, Rossana Berardi, Vanna Chiarion-Sileni, Marco Tucci, Teresa Troiani, Barbara Melotti, Ernesto Rossi, Mario Mandala, Gaetana Rinaldi, Ilaria Gioia Marcon, Matteo Pizzuti, Michele Del Vecchio. Characteristics of Real-World Patients with High-Risk -Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program.Cancer management and research. 2023, 15: 1271-1281
38)- . Erratum: Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer [Corrigendum].Cancer management and research. 2023, 15: 1319-1320
41)- . Regulatory Effect of miR497-5p- Axis in Triple-Negative Breast Cancer Cells and Its Predictive Value for Early Diagnosis [Retraction].Cancer management and research. 2023, 15: 1339-1340
42)- . MiR-625 Inhibits Tumor Cell Invasion, Migration and EMT by Negatively Regulating the Expression of Resistin in Non-Small Cell Lung [Retraction].Cancer management and research. 2023, 15: 1341-1342
43)- Cui-Ping Li, Lei Li, Lin-Ming Su, Shu-Sheng Zhu, Meng-Jie Li. Challenging Diagnosis: Unmasking the Enigma of Imaging Findings with Lung Schwannomas.Cancer management and research. 2023, 15: 1343-1347
44)- Sri Winarni, Wiwin Martiningsih, Ekowati Retnaningtyas. Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer [Letter].Cancer management and research. 2023, 15: 1349-1350
45)- Gabriel Iudy Yamaguchi Rocha, Jonathas Eduardo Miranda Gomes, Michel Lopes Leite, Nicolau B da Cunha, Fabricio F Costa. Epigenome-Driven Strategies for Personalized Cancer Immunotherapy.Cancer management and research. 2023, 15: 1351-1367
46)- Katharina Gastberger, Victoria E Fincke, Marlena Mucha, Reiner Siebert, Martin Hasselblatt, Michael C Frühwald. Current Molecular and Clinical Landscape of ATRT - The Link to Future Therapies.Cancer management and research. 2023, 15: 1369-1393
47)- Meghan J Bird, Grace Li, Andie MacNeil, Ying Jiang, Margaret de Groh, Esme Fuller-Thomson. Pandemic-Induced Depression Among Older Adults with a History of Cancer During the COVID-19 Pandemic: Findings from the Canadian Longitudinal Study on Aging.Cancer management and research. 2023, 15: 937-955
48)- Weiling Zhou, Qian Gao, Lianjing Wang, Weijing Li, Cuiying He, Yanting Li, Lei Feng, Wei Liu, Lihong Liu, Yuan Wang. The Treatment of Diffuse Large B-Cell Lymphoma (Triple Expression) Involving the Breast, Spleen, and Bone in a Male Patient with Viral Hepatitis B: A Rare Case Report.Cancer management and research. 2023, 15: 983-988
49)- Ari Pelcovits, Thomas A Ollila, Adam J Olszewski. Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma.Cancer management and research. 2023, 15: 989-998
50)- . Erratum: A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma [Corrigendum].Cancer management and research. 2023, 15: 999-1001